Pharmaceutics

This page contains key pharmaceutical news on drug recalls, FDA clearance, safety communications and research. In cardiology, key pharmaceutic agents include antiplatelet therapies, anticoagulants, hypertension drugs, and drugs for heart failure and arrhythmias.   

COVID-19 vaccine vaccination myocarditis heart damage inflammation RSNA imaging radiology cardiology

COVID-19 vaccines helped heart failure patients stay out of the hospital and live longer

Vaccination was linked to key benefits in terms of all-cause mortality, heart failure hospitalizations, stroke, heart attack, myocarditis, venous thromboembolism and testing positive for COVID-19. 

heart patient

New hypertrophic cardiomyopathy guidelines highlight importance of exercise, new drug class

HCM is widely underdiagnosed, but the American College of Cardiology and American Heart Association hope their new guidelines can help cardiologists learn more about the potentially fatal condition and improve patient care. 

Thumbnail

FDA announces Class I recall after insulin pump software causes 224 injuries

The new recall impacts more than 85,000 devices. If users update their iPhone app as recommended, however, they can continue using the insulin pump as directed. 

cannabis use disorder marijuana joint weed smoking

Cardiologists want better data on how legal marijuana will impact heart health in the US

Many states have legalized the recreational use of marijuana in recent years, creating one of the more radical cultural shifts the United States has seen in quite some time. What could this trend mean from a cardiologist's perspective? 

Thumbnail

Statin therapy may help HFpEF patients lower their risk of death, heart attack or stroke

All participants were free of ASCVD and had no history of statin use at the start of the study. 

pharmaceutical drug approval process

American Heart Association thinks pharmacists can play a bigger role in AFib care

Pharmacists interact with patients on a regular basis and are seen as a trusted source of health information. Can they help cardiologists improve care for AFib patients? 

Video of James Januzzi explaining the results of a new diabetic cardiomyopathy treatment in ACC 2024 late-breaking ARISE-HF trial. #ACC #ACC24 #ACC2024

Diabetic cardiomyopathy treatment shows promise in ARISE-HF

James Januzzi Jr., MD, said the treatment's overall impact was neutral, but he and his team saw "a very clear and encouraging signal."

Sex, energy drinks and vaccines among the many topics planned for preventive cardiology conference

The three-day event will include sessions about sexual activity among heart patients, depression, energy drinks, stimulants, vaccines and more. The festivities begin Thursday, April 25, in Greece. 

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Trimed Popup
Trimed Popup